We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
676
DELISTED
Select Medical
SEM
| $1.05M | 0.01% |
88,563
-10,074
| -10% | -$143K |
|
677
Precigen
PGEN
$2.32B
| $1.05M | 0.01% |
497,190
-115,511
| -19% | -$244K |
|
678
Eastern Bankshares
EBC
$5.37B
| $1.05M | 0.01% |
53,614
-21,773
| -29% | -$435K |
|
679
OptimizeRx
OPRX
$165M
| $1.05M | 0.01% |
71,052
+18,240
| +35% | +$361K |
|
680
Autodesk
ADSK
$54.5B
| $1.05M | 0.01% |
5,626
+3,689
| +190% | +$745K |
|
|
AJRD
681
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.04M | 0.01% |
26,111
| – | – |
|
682
Academy Sports + Outdoors
ASO
$3.03B
| $1.04M | 0.01% |
24,590
-72,908
| -75% | -$3.19M |
|
|
SHOE
683
Shoe Station Group
SHOE
$415M
| $1.03M | 0.01% |
48,296
| – | – |
|
684
Steven Madden
SHOO
$3.46B
| $1.03M | 0.01% |
38,819
-19,570
| -34% | -$616K |
|
685
Weis Markets
WMK
$1.77B
| $1.03M | 0.01% |
14,457
-6,307
| -30% | -$492K |
|
686
Argan
AGX
$7.84B
| $1.03M | 0.01% |
31,878
-8,428
| -21% | -$297K |
|
687
Global Industrial
GIC
$1.49B
| $1.03M | 0.01% |
38,243
-7,092
| -16% | -$223K |
|
|
DSKE
688
DELISTED
Daseke, Inc. Common Stock
DSKE
| $1.02M | 0.01% |
189,121
+5,072
| +3% | +$32.6K |
|
689
Central Pacific Financial
CPF
$1B
| $1.02M | 0.01% |
49,380
-800
| -2% | -$18K |
|
690
Ingles Markets
IMKTA
$1.68B
| $1.02M | 0.01% |
12,856
-10,273
| -44% | -$934K |
|
691
Cass Information Systems
CASS
$750M
| $1.02M | 0.01% |
29,297
-7,894
| -21% | -$283K |
|
692
Par Pacific Holdings
PARR
$4.12B
| $1.02M | 0.01% |
61,883
-31,207
| -34% | -$530K |
|
693
Chefs' Warehouse
CHEF
$4.57B
| $1.01M | 0.01% |
+35,031
| New | +$1.22M |
|
694
Atea Pharmaceuticals
AVIR
$406M
| $1.01M | 0.01% |
177,148
-24,326
| -12% | -$186K |
|
695
Sterling Infrastructure
STRL
$16.9B
| $1.01M | 0.01% |
46,836
| – | – |
|
|
MNRL
696
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $1M | 0.01% |
40,659
+12,193
| +43% | +$326K |
|
697
Univest Financial
UVSP
$1.19B
| $995K | 0.01% |
42,378
-13,729
| -24% | -$347K |
|
698
Liberty Global Class A
LBTYA
$3.58B
| $994K | 0.01% |
63,779
-495,479
| -89% | -$9.96M |
|
699
Shoals Technologies Group
SHLS
$1.37B
| $993K | 0.01% |
46,091
+31,389
| +214% | +$701K |
|
700
Albemarle
ALB
$15.4B
| $992K | 0.01% |
+3,750
| New | +$954K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.